Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Health Policy (Amsterdam, Netherlands)|November 15, 2025
How do strategy, scanning, and assessment shape decision-making on technologies in hospitals? insights from a qualitative study in Dutch hospitalsMaria Pinelli, Marcia Tummers, Janneke GruttersThe Lancet. Oncology|April 4, 2012
Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?Judith van Loon, Janneke Grutters, Fergus MacbethMedical Decision Making : an International Journal of the Society for Medical Decision Making|September 7, 2018
Value of Information Choices that Influence Estimates: A Systematic Review of Prevailing ConsiderationsHendrik Koffijberg, Claire Rothery, Kalipso Chalkidou, et al.Prostate Cancer and Prostatic Diseases|January 22, 2019
Exploring the risk-reward balance in focal therapy for prostate cancer-a contribution to the debateAnouck Kluytmans, Jurgen J Fütterer, Mark Emberton, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Early Assessment of Proof-of-Problem to Guide Health InnovationAnouck Kluytmans, Marcia Tummers, Gert Jan van der Wilt, et al.Head & Neck|July 4, 2014
Cost-effectiveness of selective neck dissection versus modified radical neck dissection for treating metastases in patients with oral cavity cancer: A modelling studyTim M Govers, Sejal Patel, Robert P Takes, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
The role of the expected value of individualized care in cost-effectiveness analyses and decision makingAukje van Gestel, Janneke Grutters, Jan Schouten, et al.Family Practice|August 15, 2014
Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary careRhona Eveleigh, Janneke Grutters, Esther Muskens, et al.Pharmacoeconomics|November 12, 2019
Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision ModelsSabine E Grimm, Xavier Pouwels, Bram L T Ramaekers, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2009
High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoLMadelon Pijls-Johannesma, Ruud Houben, Liesbeth Boersma, et al.Pageof 3